173 related articles for article (PubMed ID: 32816938)
21. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
22. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
23. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
24. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, Treatment, and Follow-Up Strategy.
Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
[TBL] [Abstract][Full Text] [Related]
25. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
26. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
[TBL] [Abstract][Full Text] [Related]
27. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
Fugazzola L
Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
[No Abstract] [Full Text] [Related]
28. [Cervical lymph node metastasis in medullary thyroid carcinoma].
Yan D; Zhang B; Li Z; Wu Y; Liu S; Liu W; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 50(4):290-4. PubMed ID: 26081082
[TBL] [Abstract][Full Text] [Related]
29. Clinico-pathological and prognostic findings on 27 cases of medullary thyroid carcinoma.
Gabsi A; El Amine El Hadj O; Goucha A; Said G; Laabidi B; Gamoudi A
Tunis Med; 2017 Feb; 95(2):97-102. PubMed ID: 29424867
[TBL] [Abstract][Full Text] [Related]
30. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
31. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
[TBL] [Abstract][Full Text] [Related]
32. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer.
Kartal Baykan E; Erdoğan M
Turk J Med Sci; 2021 Apr; 51(2):650-656. PubMed ID: 33128357
[TBL] [Abstract][Full Text] [Related]
33. Unusual gastric mucosal infiltration by a medullary thyroid carcinoma: a case report.
Karrasch T; Doppl W; Roller FC; Schäffler A; Schäffer R; Gattenlöhner S
J Med Case Rep; 2016 Jul; 10():208. PubMed ID: 27461534
[TBL] [Abstract][Full Text] [Related]
34. Radioguided hepatic resection with
López-Gómez J; Medina-Ornelas S; Salazar-Álvarez MA; Álvarez-Bojórquez M; Zaragoza-Cruz N; Melchor-Ruan J; Álvarez-Cano A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):244-249. PubMed ID: 29754940
[TBL] [Abstract][Full Text] [Related]
35. What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
Asarkar A; Chang BA; Nathan CO
Laryngoscope; 2021 Mar; 131(3):458-459. PubMed ID: 32311764
[No Abstract] [Full Text] [Related]
36. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.
Cho YY; Jang HW; Jang JY; Kim TH; Choe JH; Kim JH; Kim JS; Kim SW; Chung JH
Head Neck; 2016 Oct; 38(10):1501-8. PubMed ID: 27062421
[TBL] [Abstract][Full Text] [Related]
37. A 9 years boy with MEN-2B variant of medullary thyroid carcinoma.
Sattar MA; Hadi HI; Ekramuddoula FM; Hasanuzzaman SM
Mymensingh Med J; 2013 Apr; 22(2):406-9. PubMed ID: 23715371
[TBL] [Abstract][Full Text] [Related]
38. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
40. The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.
Spaulding SL; Ho R; Everest S; Chai RL
Am J Otolaryngol; 2020; 41(1):102312. PubMed ID: 31727331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
